Citalopram HBR
| CAT NO | : LP - 2700-01-001 |
| CAS NO | : 59729-32-7 |
| Mol.F | : C20H21FN2O·HBr |
| Mol.Wt. | : 405.3 |
Citalopram EP Impurity - A
| CAT NO | : LP - 2700-01-001 |
| CAS NO | : 59729-32-7 |
| Mol.F | : C20H21FN2O·HBr |
| Mol.Wt. | : 405.3 |
Citalopram EP Impurity - B
| CAT NO | : LP - 2700-01-001 |
| CAS NO | : 59729-32-7 |
| Mol.F | : C20H21FN2O·HBr |
| Mol.Wt. | : 405.3 |
Citalopram EP Impurity - C
| CAT NO | : LP - 2700-01-001 |
| CAS NO | : 59729-32-7 |
| Mol.F | : C20H21FN2O·HBr |
| Mol.Wt. | : 405.3 |
Citalopram EP Impurity - D
| CAT NO | : LP - 2700-01-001 |
| CAS NO | : 59729-32-7 |
| Mol.F | : C20H21FN2O·HBr |
| Mol.Wt. | : 405.3 |
Citalopram USP Related Compound - A
| CAT NO | : LP - 2700-01-001 |
| CAS NO | : 59729-32-7 |
| Mol.F | : C20H21FN2O·HBr |
| Mol.Wt. | : 405.3 |
Citalopram USP Related Compound - B
| CAT NO | : LP - 2700-01-001 |
| CAS NO | : 59729-32-7 |
| Mol.F | : C20H21FN2O·HBr |
| Mol.Wt. | : 405.3 |
Citalopram USP Related Compound - C
| CAT NO | : LP - 2700-01-001 |
| CAS NO | : 59729-32-7 |
| Mol.F | : C20H21FN2O·HBr |
| Mol.Wt. | : 405.3 |
Citalopram USP Related Compound - D
| CAT NO | : LP - 2700-01-001 |
| CAS NO | : 59729-32-7 |
| Mol.F | : C20H21FN2O·HBr |
| Mol.Wt. | : 405.3 |
Citalopram USP Related Compound - E
| CAT NO | : LP - 2700-01-001 |
| CAS NO | : 59729-32-7 |
| Mol.F | : C20H21FN2O·HBr |
| Mol.Wt. | : 405.3 |
R-Citalopram USP Oxalate Impurity
| CAT NO | : LP - 2700-01-001 |
| CAS NO | : 59729-32-7 |
| Mol.F | : C20H21FN2O·HBr |
| Mol.Wt. | : 405.3 |
Citalopram Impurity(Dimethyl amino butyryl Citalopram)
| CAT NO | : LP - 2700-01-001 |
| CAS NO | : 59729-32-7 |
| Mol.F | : C20H21FN2O·HBr |
| Mol.Wt. | : 405.3 |
Citalopram Impurity
| CAT NO | : LP - 2700-01-001 |
| CAS NO | : 59729-32-7 |
| Mol.F | : C20H21FN2O·HBr |
| Mol.Wt. | : 405.3 |
Citlaopram Diol Impurity
| CAT NO | : LP - 2700-01-001 |
| CAS NO | : 59729-32-7 |
| Mol.F | : C20H21FN2O·HBr |
| Mol.Wt. | : 405.3 |
CATEGORY : Citalopram HBR
TOTAL PRODUCTS :14
FILTER BY : API
